Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ferrier and Horsley in America, 1888: cerebral localization and neurosurgery.

Proceedings (Baylor University. Medical Center)·2026
Same author

Neurological signs of possible diagnostic value in the cognitive clinic: past, present and future.

Practical neurology·2026
Same author

Andrea Rabagliati (1843-1930).

Journal of neurology·2026
Same author

Helen Gertrude Leyton (1874-1959).

Journal of neurology·2026
Same author

Late 19th-century connections between Irish psychological medicine and the West Riding Asylum, Wakefield, England.

History of psychiatry·2026
Same author

Women and the Neurological Society, 1897-1907.

Journal of the history of the neurosciences·2026
Same journal

The Machine Is Just as Loud: On Privilege, Fear, and the Duty to Advocate.

JAMA neurology·2026
Same journal

Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors.

JAMA neurology·2026
Same journal

Football-Specific On-Pitch Concussion Assessment Protocol-International Consensus Recommendations.

JAMA neurology·2026
Same journal

Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers.

JAMA neurology·2026
Same journal

Diminishing Returns of Novel Autoantibody Discovery in Encephalitis.

JAMA neurology·2026
Same journal

Superficial Siderosis and a Spinal Cord Cleft.

JAMA neurology·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Elderly individuals with FTLD

Atik Baborie, Tim D Griffiths, Evelyn Jaros

    JAMA Neurology
    |March 13, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
    08:07

    Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

    Published on: November 23, 2019

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
    09:33

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

    Published on: July 28, 2013

    Related Experiment Videos

    Last Updated: May 13, 2026

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
    08:07

    Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

    Published on: November 23, 2019

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
    09:33

    Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

    Published on: July 28, 2013